Fetal and Neonatal Heart Monitor Market Report

To increase the capabilities of their neonatal devices, new fetal and neonatal heart monitor suppliers are working on integrating advanced technology such as artificial intelligence (AI), machine learning (ML), and so on. Janitri, an Indian start-up, focuses on offering medical-grade fetal monitoring and maternal monitoring solutions to reduce maternal death rates and minimise premature births in the Indian population. The firm offers the Keyar Patch, a plastic and silicone patch that can be applied to a pregnant woman's abdomen and allows remote monitoring of the mother's heart rate, fetal heart rate, fetal movements, etc. Additional fetal monitor manufacturers are also raising extra funding to fuel their research and development activities and expand their global company reach. Raydiant Oximetry Inc., a firm specialising in maternal and fetal health monitoring, announced the start of its Series B fundraising round in February 2023, with an investment from the March of Dimes Innovation Fund. In a clinical study, the company successfully demonstrated its revolutionary LUMERAHTM technology with 95% sensitivity and 85.5% specificity for fetal distress. This excellent presentation was intended to help the firm meet its Series B investment objective of US$ 25 million.

Stringent regulations and safety standards are projected to be major hurdles for industry participants in the future. On the contrary, declining birth rates and changing women's decisions to have children late or not at all are expected to hurt fetal and neonatal heart monitor shipments in the long run. The lack of developed healthcare infrastructure and the lack of availability of neonatal healthcare provision are also projected to hamper market expansion over the forecast period. Reduced birth rates in numerous areas, along with strict regulations on fetal heart monitor production and usage, are constraining market growth. The decreased amount of births has a direct effect on the need for these products, and stringent regulatory criteria increase the difficulty and expense of launching new items in the market. The combination of these factors presents substantial challenges for manufacturers and could impede the growth of the fetal heart monitor market.

Several technologies in the category of heart monitors designed for foetuses and newborns are currently improving prenatal and neonatal care fields. Some of the advances include introducing highly effective sensors, which offer real-time tracing of fetal and neonatal heart rates to improve interventions in response to adverse indicators. Since most communication systems are wireless connected and the storage and retrieval of data is done through clouds, this assures constant monitoring of patients’ conditions and data, and efficient management of these patients. Further, integrating AI and machine learning in these monitors improves the prognosis characteristics and helps in the identification of possible problems before they become more severe and lead to negative outcomes. These technologies improve the accuracy of diagnosis and the process of integration and analysis of data leading to more informed clinical decisions and better outcomes for mothers and babies. Technologies like wireless monitoring, sophisticated imaging techniques, and AI applications enable care providers to give a better chance to mothers and babies by catching a problem before it becomes a big issue.

The advanced healthcare infrastructure of the United States presents a favourable setting for providers of fetal and neonatal heart monitors. Rising neonatal health monitoring awareness and fetal care spending among pregnant women in the nation are also expected to boost fetal and neonatal heart monitor demand in the future. Long-term market expansion is also expected to be aided by high spending in health care research and development activities in the United States. According to data published by the Centres for Medicare & Medicaid Services (CMS), National Health Expenditures (NHE) are expected to rise 5.1% per year on average between 2021-2030. Declining birth rates and an increase in preterm births are variables that may encourage the use of neonatal and fetal care devices in the country in the future. According to the US Department of Health & Human Services, in 2021, preterm birth affected about 1 of every 10 infants born in the United States. From 10.1% in 2020 to 10.5% in 2021, the preterm birth rate increased by 4%. Favourable reimbursement policies and the availability of adequate medical insurance coverage for neonatal treatment in the United States are expected to drive demand for fetal and neonatal heart monitors in the future years through 2033.